e-learning
resources
ERJ
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Inhaled corticosteroids preventing pneumonia mortality: paradox or selection bias?
Samy Suissa
Source:
Eur Respir J, 53 (2) 1802112; 10.1183/13993003.02112-2018
Journal Issue:
February
Disease area:
Airway diseases
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
Samy Suissa. Inhaled corticosteroids preventing pneumonia mortality: paradox or selection bias?. Eur Respir J, 53 (2) 1802112; 10.1183/13993003.02112-2018
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Management of severe community acquired pneumonia – ERS guidelines
The Relationship Between Functional Status and Fatigue After COVID-19 Infection
Observational cohort study of pulmonary exacerbations in alpha-1 antitrypsin deficiency
Related content which might interest you:
Inhaled steroids and mortality in COPD: bias from unaccounted immortal time
Source: Eur Respir J 2004; 24: 190-191
Year: 2004
Inhaled beta2-agonists and death for asthma: can we overcome this risk?
Source: Annual Congress 2007 - Effect of long acting beta-agonists on severe asthma exacerbations and asthma-related deaths
Year: 2007
Inhaled corticosteroids in COPD: a case in favour
Source: Eur Respir J 2009; 34: 10-12
Year: 2009
Inhaled corticosteroids and pneumonia mortality in COPD patients
Source: Eur Respir J, 54 (3) 1901035; 10.1183/13993003.01035-2019
Year: 2019
Inhaled corticosteroids and pneumonia mortality in COPD patients
Source: Eur Respir J, 54 (3) 1901276; 10.1183/13993003.01276-2019
Year: 2019
Inhaled therapy reduces COPD mortality
Source: ERJ Open Res, 6 (4) 00634-2020; 10.1183/23120541.00634-2020
Year: 2020
Does inhaled corticosteroid use affect the risk of ?COVID-19-related death?
Source: Breathe, 17 (1) 200275; 10.1183/20734735.0275-2020
Year: 2021
Is there a problem with inhaled corticosteroid use in COPD?
Source: Virtual Congress 2020 – Airway diseases
Year: 2020
Inhaled antibiotics in ventilator-associated pneumonia: treatment or prophylaxis?
Source: International Congress 2016 – PG13 Inhaled antibiotics in respiratory infections
Year: 2016
Inhaled corticosteroid therapy reduces the risk of rehospitalization and all-cause mortality in elderly asthmatics
Source: Eur Respir J 2001; 17: 380-385
Year: 2001
Inhaled corticosteroid use is associated with lower mortality for subjects with COPD and hospitalised with pneumonia
Source: Eur Respir J 2010; 36: 751-757
Year: 2010
Low-dose corticosteroids during severe community-acquired pneumonia: end of the story
Source: Eur Respir J 2015; 45: 305-307
Year: 2015
Inhaled beta2-agonists in asthma management: an evolving story
Source: Breathe 2016; 12: 375-377
Year: 2016
Asthma progression and mortality: the role of inhaled corticosteroids
Source: Eur Respir J, 54 (1) 1900491; 10.1183/13993003.00491-2019
Year: 2019
Are COPD patients with pneumonia who are taking inhaled corticosteroids at higher risk of dying?
Source: Eur Respir J 2011; 37: 1-3
Year: 2011
Inhaled corticosteroids and the risk of pneumonia in Medicare patients with COPD
Source: Annual Congress 2012 - COPD: risk factors, biomarkers and diagnosis
Year: 2012
Inhaled drugs as risk factors for community-acquired pneumonia
Source: Annual Congress 2010 - The spectrum of lower respiratory tract infections: risk factors of poor outcome and diagnostic tools
Year: 2010
Inhaled corticosteroid related pneumonia in real world among the patients with asthma and COPD
Source: International Congress 2017 – Asthma and allergy: from the bench to the bedside
Year: 2017
Inhaled steroids as an intervention on long-term outcome of cough variant asthma
Source: Eur Respir J 2001; 18: Suppl. 33, 97s
Year: 2001
Inhaled corticosteroids in COPD: the case against
Source: Eur Respir J 2009; 34: 13-16
Year: 2009
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept